Novo Nordisk, the Danish maker of Ozempic and Wegovy, plans to reduce its workforce by 11 percent. This move comes as the company faces growing competition, particularly from U.S. rival Eli Lilly.

Gold may be approaching a significant upswing, as leading market analyses—Gann and a Probability Indicator—align. This convergence suggests that the metal could be gearing up for a bullish breakout in the near future.